Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

BACKGROUND: Quantitative skeletal muscle mass loss has the potential to predict the therapeutic effects of immune checkpoint inhibitors. This study aimed to assess the impact of muscular quality on the abovementioned outcomes. METHODS: This study retrospectively reviewed the medical records of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishioka, Naoya, Naito, Tateaki, Notsu, Akifumi, Mori, Keita, Kodama, Hiroaki, Miyawaki, Eriko, Miyawaki, Taichi, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Wakuda, Kazushige, Ono, Akira, Kenmotsu, Hirotsugu, Murakami, Haruyasu, Takayama, Koichi, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826480/
https://www.ncbi.nlm.nih.gov/pubmed/33300678
http://dx.doi.org/10.1002/cam4.3631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826480/
https://www.ncbi.nlm.nih.gov/pubmed/33300678
http://dx.doi.org/10.1002/cam4.3631

Ejemplares similares